Vanderbilt University Medical Center

Open enrollment with an early-phase pipeline tilt

According to ClinicalTrials.gov-derived indexes, Vanderbilt University Medical Center sits in the top decile of US sponsors by registered trial count (#51 of 15,742 sponsors by registered trial count).

677 total trials 130 currently recruiting 400 completed early-phase tilt top decile by trial count

Vanderbilt University Medical Center: 677 sponsored US clinical trials, 130 recruiting.

Vanderbilt University Medical Center sponsors 677 registered US clinical trials on ClinicalTrials.gov, 130 of them currently recruiting, and 400 completed. 70 of these trials are in Phase 3-4 (later-stage) and 127 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Autonomic Failure, with 9 trials.

Top-decile sponsor footprint

Vanderbilt University Medical Center ranks in the top decile of sponsors by registered trial count (#51 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

D 54/100

400 of 467 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (85.7%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

Open and recent trials

677 total, page 9 of 14

COMPLETED NA

Improving CarE for Community Acquired Pneumonia 1

NCT03760419

COMPLETED

Kinetics of the Immune Response to Inactivated Influenza Vaccine in Healthy Adults

NCT03743688

TERMINATED Phase 1

Imaging Activated Macrophages in the Lungs

NCT03494114

TERMINATED Phase 2

PROCLAIM -- Misoprostol in the Prevention of Recurrent CDI Prevent Recurrence of Clostridium Difficile Infection With Misoprostol

NCT03617172

TERMINATED Phase 4

Mechanism(s) Underlying Hypotensive Response to ARB/NEP Inhibition - Aim 1

NCT03738878

COMPLETED NA

Assessing Efficacy of Neuropsychiatric Assessment and Treatment Protocols in Huntington's Disease Patients

NCT03417583

COMPLETED

Vitamin D to Improve Outcomes by Leveraging Early Treatment: Long-term Brain Outcomes in Vitamin D Deficient Patients

NCT03733418

TERMINATED Phase 4

Comparison of Dexamethasone Oral Preparations to Assess Taste and Acceptance in Children With Asthma and Croup

NCT03705273

COMPLETED Phase 4

Safety of LAIV4 in Children With Asthma

NCT03600428

COMPLETED NA

Oatmeal Effect on N-acyl-phosphatidylethanolamines

NCT03468179

COMPLETED Phase 2

Tamoxifen Therapy to Treat Pulmonary Arterial Hypertension

NCT03528902

COMPLETED Phase 4

Pain Outcomes Following Intralesional Corticosteroid Injections

NCT03630198

COMPLETED NA

Discharge Opioid Education to Decrease Opioid Use After Cesarean

NCT03678870

COMPLETED Phase 4

Efficacy of Short Term Dabigatran Etexilate Followed by Aspirin Monotherapy After LAA (Left Atrial Appendage) Device Closure (the DEA-LAA Study).

NCT03539055

COMPLETED Phase 2

Interventions Against Insulin Resistance in Pulmonary Arterial Hypertension

NCT03617458

TERMINATED

Longitudinal Outcomes of DBS in PD

NCT03582163

COMPLETED NA

Gravity- Versus Suction-driven Large Volume Thoracentesis

NCT03591952

TERMINATED NA

Telenursing and Remote Monitoring in Idiopathic Pulmonary Fibrosis (IPF)

NCT03562247

TERMINATED NA

Goal of Open Lung Ventilation in Donors

NCT03439995

COMPLETED NA

Pilot Sleep Intervention to Improve Diabetes Management in School-Aged Children

NCT03397147

COMPLETED NA

Using Patient-Centered Guidelines in a Technology Platform to Improve Health Care in Adults With Sickle Cell Disease

NCT03629678

COMPLETED NA

Pragmatic Investigation of optimaL Oxygen Targets Trial

NCT03537937

TERMINATED Phase 4

Comparison of Methods for Prevention of Urinary Tract Infection Following Botox Injection

NCT03508921

TERMINATED Phase 1

Orthostatic Intolerance After Bariatric Surgery

NCT03808740

COMPLETED NA

Promotora Navigator - Culturally Appropriate Patient Navigator

NCT03557801

COMPLETED NA

Balanced Solutions and Plasma Electrolytes

NCT03537898

COMPLETED NA

Evaluation of a Daily Brief Exercise Intervention on Resident Physician Personal Resiliency and Burnout

NCT03489720

COMPLETED

Platelet PAR-1 Activation in Health and Diabetes

NCT04280549

COMPLETED NA

The Impact of Branched-Chain Amino Acid Metabolism on Limb Dysfunction in PAD

NCT03490968

COMPLETED Phase 2

PRecision Interventions for SMoking in the SCCS

NCT03521141

COMPLETED Phase 2

Soluble Epoxide Hydrolase Inhibition and Insulin Resistance

NCT03486223

COMPLETED NA

SeRenade Parent-Child Music Class Program

NCT03560297

COMPLETED NA

CrYobiopsy With Radial UltraSound Guidance

NCT03506295

COMPLETED

Collaborative Assessment of ICU Recovery Needs

NCT03513289

COMPLETED

Non-Motor Features of Cervical Dystonia (CD)

NCT03471923

COMPLETED NA

Strategies for Teaching Verbs

NCT03441685

COMPLETED Phase 4

Intra-articular Doxycycline: A Novel Treatment of Adhesive Capsulitis

NCT03479502

COMPLETED NA

Impact of a Procalcitonin Testing and Treatment Algorithm on Antibiotic Use and Outcomes in the Pediatric Intensive Care Unit

NCT03440918

TERMINATED Phase 1

Examination of the Metabolic Effects of Direct Bile Salt Delivery to the Ileum in Humans

NCT03201952

COMPLETED

Validity and Inter-Rater Reliability of a Novel Bedside Referral Tool for Spasticity

NCT03209960

COMPLETED

Using Telemedicine to Improve Spasticity Diagnosis Rates

NCT03211390

COMPLETED

Prevalence of Comorbid Spasticity and Urinary Incontinence in Residents of a Long-Term Care Facility

NCT03250988

TERMINATED NA

Plastic vs. Fully Covered Self Expanding Stents (FCSEMS) for Treatment of Anastomotic Bile Leaks

NCT03333382

COMPLETED NA

Genicular Radiofrequency Ablation Efficacy in Achieving Total Knee Pain Reduction Trial

NCT02947321

TERMINATED

Peripheral Venous Analysis (PIVA) for Predicting Volume Responsiveness and Fluid Status

NCT03407287

COMPLETED Phase 1

A Pilot Trial of Herpesvirus Treatment in Idiopathic Pulmonary Fibrosis (IPF)

NCT02871401

COMPLETED NA

Pharyngeal Anatomy In Obstructive Sleep Apnea With HRM

NCT03198416

COMPLETED NA

Investigating Social Competence in Youth With Autism

NCT03368001

COMPLETED NA

Covered vs Uncovered Metal Stents for Palliative Biliary Decompression in Inoperable Malignant Distal Bile Duct Obstruction

NCT01905384

COMPLETED NA

A pragmatiC sTrategy to Promote actIVity and Enhance Quality of Life AFTER Transcatheter Aortic Valve Replacement

NCT03270124

← Previous Page 9 of 14 Next →

Phase Distribution

PhaseTrial count
Phase 1 65
Phase 2 62
Phase 3 14
Phase 4 56

What is open in the Vanderbilt University Medical Center pipeline

130 recruiting of 677 indexed (19% open); 400 completed (59%).

Phase mix: 70 late (III/IV) vs 127 early (I/II) (early-phase heavy).

Top condition: Autonomic Failure (9 trials), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

Vanderbilt University Medical Center: open-pipeline peers nationwide

Peers matched on 677 registered trials and 19% open enrollment, not the therapeutic-area sidebar.

Vanderbilt University Medical Center sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 01,0002,0003,000 12%14%16%18%20%22%24% Total trials Recruiting share Vanderbilt University Medical CenterThe Cleveland ClinicUniversity of California, DavisWeill Medical College of Cornell UniversityIcahn School of Medicine at Mount SinaiCalifornia Polytechnic State University-San Luis ObispoPhoenix Children's HospitalMayo ClinicUniversity of South Carolina
Vanderbilt University Medical Center sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Vanderbilt University Medical Center sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 677 trials (± recruiting share)

Sponsors near 19% open enrollment (± trial volume)

What to do with this Vanderbilt University Medical Center page

677 registered trials is a research-attention snapshot, not an endorsement of Vanderbilt University Medical Center or any single study.

  • 130 of Vanderbilt University Medical Center's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Autonomic Failure is the condition Vanderbilt University Medical Center studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Autonomic Failure trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Vanderbilt University Medical Center pipeline card: 677 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.